Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Recurrence and PTGS1[original query] |
---|
Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004 May 13 (5): 889-93. Ulrich Cornelia M, Bigler Jeannette, Sparks Rachel, Whitton John, Sibert Justin G, Goode Ellen L, Yasui Yutaka, Potter John |
Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial. International journal of cancer. Journal international du cancer 2007 Nov 121 (9): 2001-4. Hubner Richard A, Muir Kenneth R, Liu Jo-Fen, Logan Richard F A, Grainge Matthew J, Houlston Richard S, |
Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs. The American journal of cardiology 2010 Jun 105 (12): 1740-5. St Germaine Christine G, Bogaty Peter, Boyer Luce, Hanley James, Engert James C, Brophy James |
Polymorphisms in Cyclooxygenase, Lipoxygenase and TP53 genes predict colorectal polyp risk reduction by aspirin in the seAFOod polyp prevention trial. Cancer prevention research (Philadelphia, Pa.) 2023 9 . John R Davies, Tracey Mell, Harriett Fuller, Mark Harland, Rasha Nm Saleh, Amanda D Race, Colin J Rees, Louise C Brown, Paul M Loadman, Amy Downing, Anne Marie Minihane, Elizabeth A Williams, Mark A Hu |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: